Dr.Reddy's news

Growth in US, local market to pep up DRL

Dr Reddy's Lab takes a breathe...

Option Skews - Relatively Heavy Put Activity on Potash Corp. of Saskatchewan, Dr. Reddy's Laboratories Ltd, PNC Financial Services

Dr Reddy's voluntarily recalls 4 drugs from US

Reuters - 14 minutes ago
BANGALORE, Sept 30 (Reuters) - Indian drug maker Dr Reddy's Laboratories Ltd (REDY.BO) said on Wednesday it had voluntarily recalled four products from its key US market as they had been observed ...

Dr Reddy's:Voluntarily Recalling Some Products From US Market

Wall Street Journal - 2 minutes ago
BANGALORE (Dow Jones)--India's Dr. Reddy's Laboratories Ltd. (500124.BY) said Wednesday the company is voluntarily recalling four products from the US market as a precaution as some lots contained ...

Skindia GDR Index signals flat Nifty opening

Myiris.com - 19 minutes ago
The decrease in the premium of the Skindia GDR Index 0.80% on Wednesday`s over previous close indicates a flat Nifty opening. The Skindia GDR Index closed 0.19% higher on September 29, 2009 at ...

Research Oracle roundup for 29 September 2009

Research Oracle - 4 hours ago
The common stock price for Dr. Reddy's Laboratories Limited (NYSE:RDY) has appreciated 22.9% since our 1Q 10 update report, dated 07 August 2009 following reports which suggested that UK-based ...

Dr. Reddy's Laboratories Limited (NYSE:RDY) – Significant appreciation in common stock price since our 1Q 10 update report.

Dr Reddy`s gains 2.50% on USFDA nod for antihistamine drugs

Myiris.com - 31 minutes ago
Drug maker Dr Reddy`s (Q,N,C,F)* Laboratories has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Fexofenadine Hydrochloride; Pseudoephedrine ...

Reddy's set for brace of generic gains

DNA India - 4 minutes ago
Dr Reddy's Laboratories (DRL) is set to reap yet another round of benefits from generics, with copies of Allegra and Lotrel expected to hit the market shortly. Allegra, innovated by Aventis, is ...